Luísa L. Gonçalves

Dr. Luísa L. Gonçalves

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2003 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
CCCarlos A. Cunha
Carlos A. Cunha
SMSofia Macieira
Sofia Macieira
JDJoão M. Dias
João M. Dias
MAM. Gabriela Almeida
M. Gabriela Almeida
LGLuísa L. Gonçalves
Luísa L. Gonçalves
MRMaria Joao Romão
Maria Joao Romão
The gene encoding cytochrome cnitrite reductase (NrfA) from Desulfovibrio desulfuricansATCC 27774 was sequenced and the crystal structure of the enzyme was determined to 2.3-Å resolution. In comparison with homologous structures, it presents structural differences mainly located at the regions surrounding the putative substrate inlet and product outlet, and includes a well defined second calcium site with octahedral geometry, coordinated to propionates of hemes 3 and 4, and caged by a loop non-existent in the previous structures. The highly negative electrostatic potential in the environment around hemes 3 and 4 suggests that the main role of this calcium ion may not be electrostatic but structural, namely in the stabilization of the conformation of the additional loop that cages it and influences the solvent accessibility of heme 4. The NrfA active site is similar to that of peroxidases with a nearby calcium site at the heme distal side nearly in the same location as occurs in the class II and class III peroxidases. This fact suggests that the calcium ion at the distal side of the active site in the NrfA enzymes may have a similar physiological role to that reported for the peroxidases.

3 September 2003 in European Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
MAM. Gabriela Almeida
M. Gabriela Almeida
SMSofia Macieira
Sofia Macieira
LGLuísa L. Gonçalves
Luísa L. Gonçalves
RHRobert Huber
Robert Huber
CCCarlos A. Cunha
Carlos A. Cunha
IMIsabel Moura
Isabel Moura
The cytochrome c nitrite reductase is isolated from the membranes of the sulfate‐reducing bacterium Desulfovibrio desulfuricans ATCC 27774 as a heterooligomeric complex composed by two subunits (61 kDa and 19 kDa) containing c‐type hemes, encoded by the genes nrfA and nrfH, respectively. The extracted complex has in average a 2NrfA:1NrfH composition. The separation of ccNiR subunits from one another is accomplished by gel filtration chromatography in the presence of SDS. The amino‐acid sequence and biochemical subunits characterization show that NrfA contains five hemes and NrfH four hemes. These considerations enabled the revision of a vast amount of existing spectroscopic data on the NrfHA complex that was not originally well interpreted due to the lack of knowledge on the heme content and the oligomeric enzyme status. Based on EPR and Mössbauer parameters and their correlation to structural information recently obtained from X‐ray crystallography on the NrfA structure [Cunha, C.A., Macieira, S., Dias, J.M., Almeida, M.G., Gonçalves, L.M.L., Costa, C., Lampreia, J., Huber, R., Moura, J.J.G., Moura, I. & Romão, M. (2003) J. Biol. Chem. 278, 17455–17465], we propose the full assignment of midpoint reduction potentials values to the individual hemes. NrfA contains the high‐spin catalytic site (−80 mV) as well as a quite unusual high reduction potential (+150 mV)/low‐spin bis‐His coordinated heme, considered to be the site where electrons enter. In addition, the reassessment of the spectroscopic data allowed the first partial spectroscopic characterization of the NrfH subunit. The four NrfH hemes are all in a low‐spin state (S = 1/2). One of them has a gmax at 3.55, characteristic of bis‐histidinyl iron ligands in a noncoplanar arrangement, and has a positive reduction potential.

1 January 2017 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
TFTânia A. P. Fernandes
Tânia A. P. Fernandes
LGLuísa L. Gonçalves
Luísa L. Gonçalves
JBJosé Brito
José Brito
It is well established that diabetes can be detrimental to bone health, and its chronic complications have been associated with an increased risk of osteoporotic fracture. However, there is growing evidence that the skeleton plays a key role in a whole-organism approach to physiology. The hypothesis that bone may be involved in the regulation of physiological functions, such as insulin sensitivity and energy metabolism, has been suggested. Given the roles of insulin, adipokines, and osteocalcin in these pathways, the need for a more integrative conceptual approach to physiology is emphasized. Recent findings suggest that bone plays an important role in regulating intermediary metabolism, being possibly both a target of diabetic complications and a potential pathophysiologic factor in the disease itself. Understanding the relationships between bone turnover and glucose metabolism is important in order to develop treatments that might reestablish energy metabolism and bone health. This review describes new insights relating bone turnover and energy metabolism that have been reported in the literature.

1 January 1996 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
M. Matilde MarquesM. Matilde Marques
M. Matilde Marques
LGLuísa L. Gonçalves
Luísa L. Gonçalves
MSMaria Amélia Santos
Maria Amélia Santos
FBFrederick A. Beland
Frederick A. Beland

18 April 2011 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
CLCrystal J. J. Lee
Crystal J. J. Lee
LGLuísa L. Gonçalves
Luísa L. Gonçalves
PWPeter G. Wells
Peter G. Wells
Thalidomide (TD) causes birth defects in humans and rabbits via several potential mechanisms, including bioactivation by embryonic prostaglandin H synthase (PHS) enzymes to a reactive intermediate that enhances reactive oxygen species (ROS) formation. We show herein that TD in rabbit embryo culture produces relevant embryopathies, including decreases in head/brain development by 28% and limb bud growth by 71% ( P <0.05). Two TD hydrolysis products, 2‐phthalimidoglutaramic acid (PGMA) and 2‐phthalimidoglutaric acid (PGA), were similarly embryopathic, attenuating otic vesicle (ear) and limb bud formation by up to 36 and 77%, respectively ( P <0.05). TD, PGMA, and PGA all increased embryonic DNA oxidation measured as 8‐oxoguanine (8‐oxoG) by up to 2‐fold ( P <0.05). Co‐ or pretreatment with the PHS inhibitors eicosatetraynoic acid (ETYA) or acetylsalicylic acid (ASA), or the free‐radical spin trap phenylbutylnitrone (PBN), completely blocked embryonic 8‐oxoG formation and/or embryopathies initiated by TD, PGMA, and PGA. This is the first demonstration of limb bud embryopathies initiated by TD, as well as its hydrolysis products, in a mammalian embryo culture model of a species susceptible to TD in vivo , indicating that all likely contribute to TD teratogenicity in vivo , in part through PHS‐dependent, ROS‐mediated mechanisms.—Lee, C. J. J., Gonçalves, L. L., Wells, P. G. Embryopathic effects of thalidomide and its hydrolysis products in rabbit embryo culture: evidence for a prostaglandin H synthase (PHS)‐dependent, reactive oxygen species (ROS)‐mediated mechanism. FASEB J. 25, 2468–2483 (2011). www.fasebj.org

1 July 2014 in Bone
Verified
Journal Article
Closed access
JBJosé Brito
José Brito
ICIsabel M. Costa
Isabel M. Costa
ASAlexandra Maia e Silva
Alexandra Maia e Silva
JMJosé M.S. Marques
José M.S. Marques
CZCarlos M. Zagalo
Carlos M. Zagalo
LGLuísa L. Gonçalves
Luísa L. Gonçalves